Literature DB >> 26403443

Correlation between MRI appearances and serum alkaline phosphatase levels in Osteogenic sarcoma.

Alok C Agrawal1, H K T Raza1, Amit Sharma1.   

Abstract

INTRODUCTION: Magnetic resonance imaging is a pictorial depiction of the patho-anatomy of a bony lesion. As different parts of the tumor in Osteogenic sarcoma concurrently undergo various biological processes i.e. osteoblastic new bone formation, cell death, necrosis, bony destruction and revascularization etc., we hypothesized that the image seen in MRI could be used to assess the tumor behavior at that time. This study was done as a preliminary study with the aim to find whether the MRI pictures can have identifiable patterns and if present whether they can be linked to biological behavior. We could identify 2 distinct patterns in T2 weighted images which correlated well with serum alkaline phosphatase a serum marker and the duration of symptoms and so we are reporting our observations. MATERIAL AND
METHOD: T2 weighted MRI pictures of 15 cases of Osteogenic sarcoma were studied for identifiable patterns in matrix. These patterns if found were to be linked to biological behavior in the form of serum alkaline phosphatase levels and duration of symptoms.
RESULTS: We could identify 2 unique patterns named by us as Group 1 Heterogeneous type (4 cases) which had a raised serum alkaline phosphatase level and had a history at presentation of less than 3 months duration. In Group 2 homogenous type (5 cases) the serum alkaline phosphatase levels were low and the cases presented after 6 months. As we could not identify any logical pattern in rest of the cases we labeled them as miscellaneous. DISCUSSION: MRI patterns can be used as markers of disease activity as there are 2 clear poles correlating well with serum alkaline phosphatase levels (high or low). Intermediate patterns may be the natural biological behavior and waxing and waning of the tumor disease activity.

Entities:  

Keywords:  MRI pattern; Osteogenic sarcoma; Serum alkaline phosphatase levels

Year:  2012        PMID: 26403443      PMCID: PMC3872812          DOI: 10.1016/j.jcot.2012.08.001

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  8 in total

1.  The prognostic value of serum alkaline phosphatase in osteosarcoma of the limbs.

Authors:  G Bacci; D Dallari; A Battistini; M Orlandi; S Ferrari; M Avella; P Picci; R Casadei; P Ruggieri
Journal:  Chir Organi Mov       Date:  1992 Apr-Jun

Review 2.  Alkaline phosphatase.

Authors:  M M Kaplan
Journal:  N Engl J Med       Date:  1972-01-27       Impact factor: 91.245

3.  Biochemical and haematological findings in malignant bone tumours.

Authors:  E Brozmanová; B SKROVINA
Journal:  Neoplasma       Date:  1974       Impact factor: 2.575

4.  Expression profiles of osteosarcoma that can predict response to chemotherapy.

Authors:  Tsz-Kwong Man; Murali Chintagumpala; Jaya Visvanathan; Jianhe Shen; Laszlo Perlaky; John Hicks; Mark Johnson; Nelson Davino; Jeffrey Murray; Lee Helman; William Meyer; Timothy Triche; Kwong-Kwok Wong; Ching C Lau
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

5.  Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma.

Authors:  E Onikul; B D Fletcher; D M Parham; G Chen
Journal:  AJR Am J Roentgenol       Date:  1996-11       Impact factor: 3.959

6.  Alkaline phosphatase levels in osteosarcoma tissue are related to prognosis.

Authors:  A M Levine; S A Rosenberg
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

7.  Imaging of intramedullary tumour spread in osteosarcoma. A comparison of techniques.

Authors:  S J O'Flanagan; J P Stack; H M McGee; P Dervan; B Hurson
Journal:  J Bone Joint Surg Br       Date:  1991-11

8.  Osteogenic sarcoma. A study of one hundred and thirty cases.

Authors:  T Ohno; M Abe; A Tateishi; K Kako; H Miki
Journal:  J Bone Joint Surg Am       Date:  1975-04       Impact factor: 5.284

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.